PHOENIX, Nov. 29, 2012 \/PRNewswire\/ -- Although molecular medicine has been lauded as a game-changing science, patients have yet to see the benefits. Until now. <\/p>\n
On Dec. 4, one of the nation's largest children's hospitals, in collaboration with a major genomics research organization and a nationally regarded university, will announce a major venture that puts genomics research into clinical practice immediately to benefit children with terminal diagnoses. <\/p>\n
Unlike other children's hospitals engaged in basic genomics research, the Institute of Molecular Medicine will take research to the next level, providing real-time access to drug therapies never before used in children. <\/p>\n
What: <\/p>\n
Announcement of a pediatric medical research institute led by an internationally respected team of physician scientists putting molecular medicine into clinical practice immediately with real-time access to drug therapies <\/p>\n
Who: <\/p>\n
Phoenix Children's Hospital, in collaboration with Translational Genomics Research Institute (TGen) and University of Arizona College of Medicine - Phoenix <\/p>\n
When: <\/p>\n
Dec. 4, 2012 3:30 p.m. EST 2:30 p.m. CST 1:30 p.m. MST 12:30 p.m. PST <\/p>\n
Where: <\/p>\n
<\/p>\n
Original post:<\/p>\n
New venture puts molecular medicine into clinical practice today<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" PHOENIX, Nov. Continue reading